These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 25292024

  • 21. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
    AlZaman AS, Mughal SA, AlZaman YS, AlZaman ES.
    Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972
    [Abstract] [Full Text] [Related]

  • 22. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
    Agarwal G, Nanda G, Lal P, Mishra A, Agarwal A, Agrawal V, Krishnani N.
    World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
    Li AQ, Zhou SL, Li M, Xu Y, Shui RH, Yu BH, Yang WT.
    PLoS One; 2015 Jun; 10(5):e0125067. PubMed ID: 25938238
    [Abstract] [Full Text] [Related]

  • 24. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY, Wang SS, Zhu MQ, Zheng L, Luo WB, Zhou ZM, Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q.
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area.
    Nissan A, Spira RM, Hamburger T, Badrriyah M, Prus D, Cohen T, Hubert A, Freund HR, Peretz T.
    Am J Surg; 2004 Jul; 188(1):62-7. PubMed ID: 15219486
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
    Ulas A, Kos T, Avci N, Cubukcu E, Olmez OF, Bulut N, Degirmenci M.
    Asian Pac J Cancer Prev; 2015 Jul; 16(4):1643-9. PubMed ID: 25743846
    [Abstract] [Full Text] [Related]

  • 39. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE, Gough M, Middleton K, Hsieh M, Furnas L, Seidl B, Gibbons K, Pyke C, Shannon C, Woodward N, Armes JE.
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.